LTP
LTR PHARMA LIMITED ORDINARYLTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
LTP
LTP
LTR PHARMA LIMITED ORDINARY
LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 28 Aug | — | — |
| 27 Aug | — | — |
| 26 Aug | — | — |
| 25 Aug | 0.09% | — |
| 24 Aug | 0.09% | — |
| 21 Aug | 0.09% | — |
| 20 Aug | 0.09% | — |
| 19 Aug | 0.09% | — |
| 18 Aug | 0.09% | — |
| 17 Aug | 0.09% | — |
| 14 Aug | 0.08% | — |
| 13 Aug | 0.09% | — |
Ltr Pharma Limited (LTP) Short Interest Summary
Ltr Pharma Limited (LTP) currently has 0.09% of its shares sold short (172 thousand shares, worth approximately $81K), based on ASIC short position data reported on 25 August 2026 (T+4 reporting lag). That makes LTP the #454 most shorted stock on the ASX most shorted list. Short interest in LTP is up 0.01% over the past week and up 0.01% over the past month. LTP is part of the Health Care sector on the ASX.
Recent LTP Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 25 Aug 2026 | 0.09% | 0.2M | $0.49 |
| 24 Aug 2026 | 0.09% | 0.2M | $0.50 |
| 21 Aug 2026 | 0.09% | 0.2M | $0.49 |
| 20 Aug 2026 | 0.09% | 0.2M | $0.50 |
| 19 Aug 2026 | 0.09% | 0.2M | $0.50 |
| 18 Aug 2026 | 0.09% | 0.2M | $0.47 |
| 17 Aug 2026 | 0.09% | 0.2M | $0.48 |
| 14 Aug 2026 | 0.08% | 0.1M | $0.49 |
| 13 Aug 2026 | 0.09% | 0.2M | $0.52 |
| 12 Aug 2026 | 0.08% | 0.1M | $0.52 |
LTP Short Selling — Frequently Asked Questions
What is Ltr Pharma Limited (LTP)'s current short interest?
Ltr Pharma Limited (LTP) currently has a short interest of 0.09% of total shares outstanding. This means 0.09% of LTP's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is LTP heavily shorted on the ASX?
LTP has a relatively low short interest of 0.09%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for LTP investors?
Short interest in LTP shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.09%, LTP's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this LTP short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for LTP.